{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/crohns-disease/diagnosis/investigations/","result":{"pageContext":{"chapter":{"id":"5440444f-1635-5240-bea3-54d84e6067f5","slug":"investigations","fullItemName":"Investigations","depth":2,"htmlHeader":"<!-- begin field f9221670-4ff2-4854-936c-59a323c1b00a --><h2>How should I investigate a person with suspected Crohn's disease?</h2><!-- end field f9221670-4ff2-4854-936c-59a323c1b00a -->","summary":"","htmlStringContent":"<!-- begin item f36b0461-d72e-4051-bebf-9ac6e8049317 --><!-- begin field 3d9842c9-f125-4e3b-9f5f-484a25375131 --><ul><li><strong>If a diagnosis of Crohn's disease is <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/diagnosis/when-to-suspect/\">suspected</a>, consider arranging the following investigations in primary care, depending on local availability:</strong><ul><li>Serum full blood count — anaemia may be due to blood loss, malabsorption, or malnutrition; an increased platelet count may suggest active inflammation.</li><li>Serum inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) — may be raised if there is active inflammation or an infectious complication.</li><li>Serum urea and electrolytes — to assess for electrolyte disturbance and signs of dehydration.</li><li>Serum liver function tests, including albumin — a low serum albumin may indicate protein-losing enteropathy.</li><li>Serum ferritin, vitamin B<sub>12</sub>, folate, and vitamin D levels — may be nutritional deficiencies due to malabsorption or intestinal losses.</li><li>Coeliac serology — to exclude coeliac disease.</li><li>Stool microscopy and culture, including <em>Clostridium difficile</em> toxin — to exclude infective gastroenteritis or pseudomembranous colitis. Note: the diagnosis of a pathogen does not exclude a diagnosis of Crohn's disease, as a first episode may be triggered by enteric infection.</li><li>Faecal calprotectin (a faecal white cell marker, for adults) — if raised may suggest active inflammation (compared with a normal result which is expected in irritable bowel syndrome).</li></ul></li><li>Note that investigation results may be normal in a person with active Crohn's disease.</li></ul><!-- end field 3d9842c9-f125-4e3b-9f5f-484a25375131 --><!-- end item f36b0461-d72e-4051-bebf-9ac6e8049317 -->","topic":{"id":"a55bf0e9-c7ea-505e-b7ff-5093105336e5","topicId":"7057d96d-a527-4391-84a1-c39953de3eae","topicName":"Crohn's disease","slug":"crohns-disease","lastRevised":"Last revised in August 2020","chapters":[{"id":"9c1b7d20-f572-5a3c-845f-3f4b65f646e1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6b9f2bb0-4b7b-5373-ace6-15e38cc8904f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2a50fc53-dced-5bb1-83cf-20d5ce4f9e8e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a5629107-6649-5a0c-a706-90ad8bf14aa7","slug":"changes","fullItemName":"Changes"},{"id":"1a920dcd-3a15-527f-9fc2-97be951c56cc","slug":"update","fullItemName":"Update"}]},{"id":"79cdca68-ce3a-5435-bca1-8393c4d809a6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"123f065a-c1e6-59ef-a0f6-fa3212214c90","slug":"goals","fullItemName":"Goals"},{"id":"d3e5c61e-a5b9-586a-8698-69a0c0f79a5f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b41011e0-33e6-52d3-9434-5f29d0baeeb8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f3bcc082-58a6-51db-a805-173080268884","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a5948dc8-4eac-58f3-8d64-68a80aeb4059","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7082be71-4889-5e95-bd5f-27917f361203","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"65c06b36-b686-57f1-be7f-6fae62c4deb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3fa00303-9d62-51cf-819b-dbad0041831e","slug":"definition","fullItemName":"Definition"},{"id":"6890604a-a1f2-5be2-94b0-d2471c85fdbc","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"0d0050de-d075-540a-9c7c-ed50c6ed1243","slug":"prevalence","fullItemName":"Prevalence"},{"id":"05aa7fe4-c9b9-51f0-bf41-2369861eba6c","slug":"complications","fullItemName":"Complications"},{"id":"67cb018a-e79e-5636-bd84-67fe57bf28c2","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations"},{"id":"d2c1974d-3136-58a1-b5ba-55826ab8a286","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"14a7e92b-d43e-5b64-b357-c1a4d063afb3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"32cf487b-92a9-5d33-949e-023023aede46","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5440444f-1635-5240-bea3-54d84e6067f5","slug":"investigations","fullItemName":"Investigations"},{"id":"f7a2e718-21ad-5956-a862-8f8406ca2f8b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a49169c9-856e-51c3-94cc-76e3f02f6073","fullItemName":"Management","slug":"management","subChapters":[{"id":"c4ee1de2-52a2-5289-82bd-c3377ae84b6c","slug":"suspected-crohns-disease","fullItemName":"Scenario: Suspected Crohn's disease"},{"id":"b3e71531-764c-58b2-aa02-ece1993fb53f","slug":"confirmed-crohns-disease","fullItemName":"Scenario: Confirmed Crohn's disease"},{"id":"b822e9cd-227b-54db-9bfd-57cf52a4e663","slug":"fertility-pregnancy-breastfeeding-with-crohns-disease","fullItemName":"Scenario: Fertility, pregnancy, and breastfeeding with Crohn's disease"},{"id":"9a2be3f2-65c0-5e62-9b89-9aef0f5df386","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"82ab51ab-f7f0-5464-a0dc-cb566bb3f629","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"771b1e3f-3c10-5c86-bbb4-5ff669ca2d44","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fb296c54-fd91-56fc-ab19-6fd4bb759030","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"efff8f5f-5a26-5e56-a428-b3155279fcef","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"420029a0-c51b-5ffc-a7f3-71940eccb5ba","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"09872916-a68f-57e9-b064-aab1b782ca32","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"dc3e796d-dda1-58f4-b43f-f4ce100ebfc2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a0922fda-b50c-5cff-8ccd-19fef4fe47f1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"14a7e92b-d43e-5b64-b357-c1a4d063afb3","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"e10025be-7ff6-5320-b4bf-68b5c188bc7f","slug":"basis-for-recommendation-647","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 2725b47b-d081-4f84-8425-30e56576845a --><h3>Basis for recommendation</h3><!-- end field 2725b47b-d081-4f84-8425-30e56576845a -->","summary":null,"htmlStringContent":"<!-- begin item 647bc5e7-54f4-42a5-9669-f038cd6daf1e --><!-- begin field 70975ea8-24ee-475f-866d-ce74da6b7343 --><p>The recommendations on investigations in primary care are largely based on the National Institute for Health and Care Excellence (NICE) diagnostic guidance <em>Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2013</a>], the European Crohn's and Colitis Organisation (ECCO) publications <em>3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: Diagnosis and medical management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>], <em>European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>], the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) <em>Revised Porto Criteria for the diagnosis of inflammatory bowel disease in children and adolescents</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Levine, 2014</a>], the British Society of Gastroenterology (BSG) <em>Guidelines for the management of inflammatory bowel disease in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition (BSPGHAN) consensus document <em>Guidelines for the management of inflammatory bowel disease in children in the United Kingdom</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>], and expert opinion in review articles on Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Baumgart, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>] and inflammatory bowel disease in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Oliveira, 2017</a>].</p><ul><li>About two-thirds of people with inflammatory bowel disease have anaemia at diagnosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>].</li><li>Faecal calprotectin testing for colonic inflammation may be considered to help distinguish between inflammatory bowel disease and irritable bowel syndrome in adults with recent-onset lower gastrointestinal symptoms for whom specialist assessment is being considered [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2013</a>]. Faecal calprotectin has a greater than 90% positive predictive value for endoscopically active Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>].</li><li>Expert opinion in the ESPGHAN guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Levine, 2014</a>] and in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>] is that investigation results may be normal in a person with active Crohn's disease.</li></ul><!-- end field 70975ea8-24ee-475f-866d-ce74da6b7343 --><!-- end item 647bc5e7-54f4-42a5-9669-f038cd6daf1e -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}